Regulus Therapeutics Inc. buy Wells Fargo & Company
Start price
27.03.25
/
50%
€1.49
Target price
27.03.26
€5.57
Performance (%)
373.15%
End price
28.03.26
-
Summary
This prediction is currently being closed. With a performance of 373.15% the BUY prediction by Wells_Fargo___Compan is a big success. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regulus Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $6.00 price target on the stock, up previously from $3.00.
Ratings data for RGLS provided by MarketBeat
In the thread Trading Regulus Therapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten